Gsk (GSK) EBIT Margin (2009 - 2026)
Gsk (GSK) recorded EBIT Margin of 1167.48% in the quarter ended Jun 30, 2026, down 6450.46 percentage points from the prior quarter.
Powered by 
Analysis
Gsk (GSK) EBIT Margin (2009 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Gsk reported EBIT Margin of 24.28%, up 11.47 percentage points from the prior year.
- Annual EBIT Margin has a five-year change of -0.27 percentage points (years ended Dec 2020 to Dec 2025).
- Across earlier years, EBIT Margin came in at 12.82% in the year ended Dec 31, 2024 (-9.42 pp), 22.24% in the year ended Dec 31, 2023 (+0.30 pp), 21.94% in the year ended Dec 31, 2022 (+4.30 pp) and 17.64% in the year ended Dec 31, 2021 (-6.91 pp).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly EBIT Margin since the quarter ended Dec 31, 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 21.81% |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 28.37% |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | 5.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.72% |
| Mar 31, 2026 | 30.06% |
| Sep 30, 2025 | 30.34% |
| Jun 30, 2025 | 25.33% |
| Mar 31, 2025 | 29.48% |
| Dec 31, 2024 | 8.57% |
| Sep 30, 2024 | 2.36% |
| Jun 30, 2024 | 20.88% |
| Mar 31, 2024 | 20.24% |
| Dec 31, 2023 | 7.12% |
| Sep 30, 2023 | 23.92% |
| Jun 30, 2023 | 29.83% |
| Mar 31, 2023 | 29.95% |
| Dec 31, 2022 | 25.33% |
| Sep 30, 2022 | 15.21% |
| Jun 30, 2022 | 15.60% |
| Mar 31, 2022 | 31.89% |
| Dec 31, 2021 | 6.95% |
| Sep 30, 2021 | 20.82% |
| Jun 30, 2021 | 21.84% |
API Access
Gsk EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();